RECRUITINGOBSERVATIONAL
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers for Molecular Characterization of Inflammatory Skin Diseases
About This Trial
The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.
Who May Be Eligible (Plain English)
Who May Qualify:
All subjects:
1. Subject is willing to participate and is capable of giving willing to sign a consent form. Note: Consent must be obtained prior to any study-related procedures.
2. Subject must be willing to comply with all study procedures and must be available for the duration of the study.
Healthy volunteers:
3. Male or female subject aged 18 years or older, at the time of consent.
4. Subject is in good general health, according to the investigator's judgment.
Subjects with Acne:
5. Male or female subject aged 18 to 45 years old, inclusive, at the time of consent.
Subjects with AD:
6. Male or female subject aged 18 years or older, at the time of consent.
7. Subject has clinically confirmed diagnosis of active AD, according to Hanifin and Rajka criteria.
Subjects with CHE:
8. Male or female subject aged 18 years or older, at the time of consent.
9. Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject).
Subjects with HS:
10. Male or female subject aged 18 years or older, at the time of consent.
11. Subject has a clinically confirmed diagnosis of active HS with a disease duration of ≥ 6 months before screening as determined by the investigator through subject interview and/or review of the medical history.
Subjects with PPP:
12. Male or female subject aged 18 years or older at the time of consent.
13. Subject has at least a 6-month history of PPP as defined by the presence of pustules on palms and/or soles, but without evidence of infection on palms and soles (information obtained from medical chart or subject's physician, or directly from the subject).
Subjects with psoriasis:
14. Male or female subject aged 18 years or older, at the time of consent.
Who Should NOT Join This Trial:
All subjects:
1. Subject is a female who is pregnant or who is planning to become pregnant during the study.
...See full criteria on ClinicalTrials.gov
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
All subjects:
1. Subject is willing to participate and is capable of giving informed consent. Note: Consent must be obtained prior to any study-related procedures.
2. Subject must be willing to comply with all study procedures and must be available for the duration of the study.
Healthy volunteers:
3. Male or female subject aged 18 years or older, at the time of consent.
4. Subject is in good general health, according to the investigator's judgment.
Subjects with Acne:
5. Male or female subject aged 18 to 45 years old, inclusive, at the time of consent.
Subjects with AD:
6. Male or female subject aged 18 years or older, at the time of consent.
7. Subject has clinically confirmed diagnosis of active AD, according to Hanifin and Rajka criteria.
Subjects with CHE:
8. Male or female subject aged 18 years or older, at the time of consent.
9. Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject).
Subjects with HS:
10. Male or female subject aged 18 years or older, at the time of consent.
11. Subject has a clinically confirmed diagnosis of active HS with a disease duration of ≥ 6 months before screening as determined by the investigator through subject interview and/or review of the medical history.
Subjects with PPP:
12. Male or female subject aged 18 years or older at the time of consent.
13. Subject has at least a 6-month history of PPP as defined by the presence of pustules on palms and/or soles, but without evidence of infection on palms and soles (information obtained from medical chart or subject's physician, or directly from the subject).
Subjects with psoriasis:
14. Male or female subject aged 18 years or older, at the time of consent.
Exclusion Criteria:
All subjects:
1. Subject is a female who is pregnant or who is planning to become pregnant during the study.
2. Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.
Treatments Being Tested
PROCEDURE
Blood samples collection
biomarkers and optional genetic analysis
PROCEDURE
Oral samples collection
biomarkers analysis
PROCEDURE
Hair samples collection
biomarkers analysis
PROCEDURE
Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis
PROCEDURE
Skin surface material samples
biomarkers analysis
PROCEDURE
Drainage fluid samples collection
biomarkers analysis
PROCEDURE
Stool samples collection
biomarkers analysis
Locations (1)
Innovaderm Research Inc.
Montreal, Quebec, Canada